Dr. Kamran Idrees

Doctor Overview

Dr. Kamran Idrees is a surgical oncologist, an Ingram Associate Professor of Cancer Research and Associate Professor of Surgery at Vanderbilt University Medical Center. Dr. Idrees also serves as the Director of the Peritoneal Surface Malignancy/HIPEC Program and Director of Pancreatic and Gastro-Intestinal (GI) Surgical Oncology at the Vanderbilt-Ingram Cancer Center.

Dr. Idrees specializes in treating peritoneal malignancies, including peritoneal mesothelioma. Additionally, he has experience treating cancer patients with minimally invasive surgical techniques. Dr. Idrees also focuses on treating:

• Colorectal cancer
• Endocrine cancer
• Liver metastasis
• Pancreatic cancer

Dr. Idrees is trained to perform regional perfusion treatments, such as heated intraperitoneal chemotherapy (HIPEC). Recent research shows HIPEC with cytoreductive surgery is effective in treating peritoneal mesothelioma.

As a result of his training and experience, Dr. Idrees was recruited to lead the Peritoneal Surface Malignancy/HIPEC program at Vanderbilt University Medical Center. He has also published research in several medical journals, such as Annals of Surgical Oncology and the Journal of Gastrointestinal Surgery.

Doctor Fast Facts

Main Specialty: Surgical Oncology

Other Interests & Specialties: Benign and malignant diseases of the liver and gallbladder, bile duct cancer, colon and rectal surgery, endocrine cancer, endocrine surgery, GI cancer surgery, gastroenterology surgery, gastrointestinal, general surgery, hepatobiliary cancer surgery, hepatobiliary surgery and liver transplantation, hepatobiliary and liver surgery, kidney and pancreas surgery, pancreatic cancer surgery, sarcoma and surgical oncology.

Certifications, Awards & Accolades: Fellow of the American College of Surgeons, National Institute of Health (NIH) Clinical and Translational Science Award

Education & Experience:

• Medical Degree from The Aga Khan University Medical College
• Research Fellowship in Surgical Oncology at Memorial Sloan-Kettering Cancer Center
• Residency General Surgery at University of Alabama at Birmingham Health System
• Fellowship in Surgical Oncology at University of Pittsburgh Medical Center (UPMC)
• Fellowship in Hepatobiliary and Pancreatic Surgery at Washington University in St. Louis
• Masters of Science in Clinical Investigation from Vanderbilt University School of Medicine
• Masters of Management in Health Care from Vanderbilt University Owen Graduate School of Management

Languages Spoken:

• English
• Urdu

Publications

Adenocarcinoma Ex-Goblet Cell: a Retrospective Experience. Journal of Gastrointestinal Surgery. September 2020;24(9):2121-2126. doi: 10.1007/s11605-019-04431-6

The Chicago Consensus on Peritoneal Surface Malignancies: Management of Appendiceal Neoplasms. Annals of Surgical Oncology. June 2020;27(6):1753-1760. doi: 10.1245/s10434-020-08316-w

The Chicago Consensus on peritoneal surface malignancies: Management of peritoneal mesothelioma. Cancer. June 2020;126(11):2547-2552. doi: 10.1002/cncr.32870

Early-Onset Appendiceal Cancer Survival by Race or Ethnicity in the United States. Gastroenterology. October 2020;159(4):1605-1608. doi: 10.1053/j.gastro.2020.06.011

Fine-Needle Aspiration-Based Patient-Derived Cancer Organoids. iScience. August 2020;23(8):101408. doi: 10.1016/j.isci.2020.101408

Impact of Insurance Status on Survival in Gastroenteropancreatic Neuroendocrine Tumors. Annals of Surgical Oncology. September 2020;27(9):3147-3153. doi: 10.1245/s10434-020-08359-z

Resection of isolated distant nodal metastasis in metastatic colorectal cancer. Surgical Oncology. June 2020;33:58-62. doi: 10.1016/j.suronc.2020.01.003

Robotic liver surgery. The Surgical Clinics of North America. August 2010; 90(4):761-74. doi: 10.1016/j.suc.2010.04.020

Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable Disease. Annals of Surgery. May 2018;267(5):797-805. doi: 10.1097/SLA.0000000000002574